Purchases and Sales Made in Q4 2024 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q4 2024. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-70K- 13.06% |
$2.95M - $4.04M
|
466K
$19.9M
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-74.3K- 7.52% |
$3.13M - $4.29M
|
914K
$38.9M
|
|
Feb 11, 2025
Q4 2024
|
Td Asset Management Inc
|
SELL
|
- |
-75.6K- 44.71% |
$3.18M - $4.36M
|
93.5K
$3.98M
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-76.2K- 52.37% |
$3.2M - $4.4M
|
69.3K
$2.95M
|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-89.8K- 55.38% |
$3.78M - $5.18M
|
72.3K
$3.08M
|
|
Feb 12, 2025
Q4 2024
|
Motley Fool Asset Management LLC
Alexandria, VA |
SELL
|
- |
-93.2K- 65.8% |
$3.92M - $5.38M
|
48.4K
$2.06M
|
|
Feb 12, 2025
Q4 2024
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-105K- 4.32% |
$4.41M - $6.05M
|
2.32M
$98.9M
|
|
Feb 14, 2025
Q4 2024
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-105K- 24.43% |
$4.41M - $6.05M
|
324K
$13.8M
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-141K- 18.62% |
$5.92M - $8.12M
|
615K
$26.2M
|
|
Feb 14, 2025
Q4 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-238K- 12.05% |
$10M - $13.8M
|
1.74M
$74.1M
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-343K- 22.46% |
$14.4M - $19.8M
|
1.18M
$50.4M
|
|
Feb 14, 2025
Q4 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-400K- 53.19% |
$16.8M - $23.1M
|
352K
$15M
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-537K- 58.04% |
$22.6M - $31M
|
389K
$16.5M
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-556K- 18.13% |
$23.4M - $32.1M
|
2.51M
$107M
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-764K- 73.14% |
$32.1M - $44.1M
|
281K
$11.9M
|
|
Feb 13, 2025
Q4 2024
|
Sands Capital Management, LLC
Arlington, VA |
SELL
|
- |
-820K- 16.03% |
$34.5M - $47.3M
|
4.3M
$183M
|
|
Feb 13, 2025
Q4 2024
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-1.33M- 43.99% |
$55.7M - $76.5M
|
1.69M
$71.8M
|
|
Feb 12, 2025
Q4 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.71M- 41.0% |
$71.9M - $98.6M
|
2.46M
$105M
|